Nizhny Novgorod's 2025 Pharma Sales Topped by Hypertension Drugs
In Nizhny Novgorod, 2025 witnessed a significant shift in pharmaceutical consumption. Hypertension medications led the market, with Pfizer, Novartis, and Bayer at the forefront. Residents spent the most on these drugs, with a notable increase in expenditure despite a slight decrease in pack consumption.
Nizhny Novgorod residents bought over 67 million packs of pharmaceuticals worth 25.9 billion rubles from January to August 2025. Among these, hypertension medications held the largest market share in terms of sales volume and revenue. Pfizer, Novartis, and Bayer were the leading pharma companies in this sector.
Despite a 1.5% decrease in pack consumption, the monetary value of these drugs increased by 12.8%. This can be attributed to the 14.6% year-on-year increase in the average price per pack, which reached 384 rubles. The average checkout amount for these drugs was 743 rubles.
Residents also spent significantly on anti-inflammatory and anti-rheumatic drugs, making them the second most purchased category.
The pharmaceutical market in Nizhny Novgorod in 2025 was dominated by hypertension medications, with residents spending the most on these drugs despite a decrease in pack consumption. The increase in expenditure can be attributed to the rise in average prices. Anti-inflammatory and anti-rheumatic drugs were the second most purchased, indicating a high prevalence of these health conditions in the region.
